We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $21.5B
1-Year Est. Return 81.81%
This Fund
S&P 500
This Quarter Est. Return
+3.14%
1 Year Est. Return
+81.81%
3 Year Est. Return
+226.72%
5 Year Est. Return
+294.21%
10 Year Est. Return
AUM
$7.25B
AUM Growth
-$2.88M
Cap. Flow
-$580M
Cap. Flow %
-8%
Top 10 Hldgs %
14.3%
Holding
1,990
New
595
Increased
284
Reduced
345
Closed
531

Top Buys

Rank Stock Value
1
EQT icon
EQT Corp
EQT
+$22.4M
2
ZM icon
Zoom
ZM
+$15.7M
3
SABR icon
Sabre
SABR
+$8.12M
4
EXAS
Exact Sciences
EXAS
+$5.98M
5
OVV icon
Ovintiv
OVV
+$5.76M

Top Sells

Rank Stock Value
1
FANG icon
Diamondback Energy
FANG
+$59.9M
2
TCOM icon
Trip.com Group
TCOM
+$53.8M
3
DVN icon
Devon Energy
DVN
+$42.6M
4
FCX icon
Freeport-McMoran
FCX
+$36.7M
5
CLAR icon
Clarus
CLAR
+$26M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.49%
2 Energy 2.02%
3 Healthcare 1.54%
4 Technology 0.89%
5 Materials 0.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BNFT
1376
DELISTED
Benefitfocus, Inc.
BNFT
$59K ﹤0.01%
+9,322
New +$69.1K
ERIC icon
1377
Ericsson
ERIC
$33B
$58K ﹤0.01%
+10,000
New +$71.7K
XOM icon
1378
ExxonMobil
XOM
$678B
$58K ﹤0.01%
664
-2,536
-79% -$232K
SRNE
1379
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$57K ﹤0.01%
+36,892
New +$83.7K
MAC icon
1380
Macerich
MAC
$6.4B
$56K ﹤0.01%
7,000
W icon
1381
Wayfair
W
$14.5B
$53K ﹤0.01%
1,600
-25,800
-94% -$1.36M
IOVA icon
1382
Iovance Biotherapeutics
IOVA
$4.37B
$52K ﹤0.01%
5,397
-32,003
-86% -$369K
ABCL icon
1383
AbCellera Biologics
ABCL
$3.74B
$51K ﹤0.01%
+5,134
New +$56.3K
IHS icon
1384
IHS Holding
IHS
$2.85B
$51K ﹤0.01%
+9,000
New +$68.9K
ROIVW
1385
DELISTED
Roivant Sciences Ltd. Warrant
ROIVW
$51K ﹤0.01%
126,856
TOST icon
1386
Toast
TOST
$18.4B
$50K ﹤0.01%
+2,973
New +$51.6K
VTGN icon
1387
VistaGen Therapeutics
VTGN
$10.5M
$50K ﹤0.01%
10,972
-278
-2% -$2.75K
LEGN icon
1388
Legend Biotech
LEGN
$3.32B
$49K ﹤0.01%
+1,210
New +$56.8K
TFFP
1389
CALL
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$46K ﹤0.01%
+452
New +$61.1K
CAH icon
1390
Cardinal Health
CAH
$54.3B
$45K ﹤0.01%
676
-25,840
-97% -$1.64M
FDX icon
1391
FedEx
FDX
$71.9B
$45K ﹤0.01%
+304
New +$64.2K
NVDA icon
1392
NVIDIA
NVDA
$5.19T
$45K ﹤0.01%
3,710
-426,760
-99% -$6.75M
XLF icon
1393
State Street Financial Select Sector SPDR ETF
XLF
$54.1B
$45K ﹤0.01%
+1,477
New +$48.8K
LOGC
1394
PUT
DELISTED
ContextLogic
LOGC
$44K ﹤0.01%
+1,987
New +$82.3K
UPST icon
1395
Upstart Holdings
UPST
$2.48B
$42K ﹤0.01%
2,000
CMRX
1396
CALL
DELISTED
Chimerix, Inc.
CMRX
$41K ﹤0.01%
21,200
VIPS icon
1397
Vipshop
VIPS
$5.85B
$40K ﹤0.01%
+4,800
New +$47.8K
GKOS icon
1398
Glaukos
GKOS
$9.79B
$39K ﹤0.01%
+725
New +$37.4K
CC icon
1399
Chemours
CC
$2.21B
$38K ﹤0.01%
+1,500
New +$49.5K
ACB
1400
CALL
Aurora Cannabis
ACB
$244M
$37K ﹤0.01%
3,000

Similar funds

Caption Management's Q3 2022 Portfolio in Review

As of Q3 2022, Caption Management held 1,990 positions worth $7.25B, down 0.04% from $7.25B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Caption Management withdrew a net $580M in Q3 2022, closing 531 positions and reducing 345 holdings. Its most notable exit was US Steel, an estimated $21.7M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, up from 85% a quarter earlier, followed by Energy and Healthcare.

Against the trend, Caption Management opened a new position in Zoom worth $12.1M.

  • Caption Management's largest Q3 2022 buy was Zoom: 165,000 shares worth $12.1M.
  • Caption Management added most to EQT Corp in Q3 2022, an estimated $22.4M increase.
  • Caption Management's biggest Q3 2022 reduction was Diamondback Energy, cutting an estimated $59.9M.
  • Caption Management fully exited US Steel in Q3 2022, selling an estimated $21.7M.
  • Caption Management's ten largest holdings make up 14% of its $7.25B portfolio in Q3 2022.
  • Caption Management opened 595 new positions and closed 531 in Q3 2022.
  • Caption Management's portfolio value fell 0.04% quarter-over-quarter to $7.25B.

Based on Caption Management's 13F filing for Q3 2022, filed 14 Nov 2022.